Emmanuel Matas

Emmanuel Matas

Auto-generated profile, based on publicly available information

Emmanuel Matas

Department of Physiology and Biophysics, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, NY, 14203, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Cell Reports
Verified
Journal Article
Open access
LDLara J. Duffney
Lara J. Duffney
PZPing Zhong
Ping Zhong
JWJing Wei
Jing Wei
EMEmmanuel Matas
Emmanuel Matas
JCJia Cheng
Jia Cheng
ZYZhen Yan
Zhen Yan
Haploinsufficiency of the Shank3 gene, which encodes a scaffolding protein at glutamatergic synapses, is a highly prevalent and penetrant risk factor for autism. Using combined behavioral, electrophysiological, biochemical, imaging, and molecular approaches, we find that Shank3-deficient mice exhibit autism-like social deficits and repetitive behaviors, as well as the significantly diminished NMDA receptor (NMDAR) synaptic function and synaptic distribution in prefrontal cortex. Concomitantly, Shank3-deficient mice have a marked loss of cortical actin filaments, which is associated with the reduced Rac1/PAK activity and increased activity of cofilin, the major actin depolymerizing factor. The social deficits and NMDAR hypofunction are rescued by inhibiting cofilin or activating Rac1 in Shank3-deficient mice and are induced by inhibiting PAK or Rac1 in wild-type mice. These results indicate that the aberrant regulation of synaptic actin filaments and loss of synaptic NMDARs contribute to the manifestation of autism-like phenotypes. Thus, targeting actin regulators provides a strategy for autism treatment.

12 March 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
LQLuye Qin
Luye Qin
KMKaijie Ma
Kaijie Ma
ZWZi-Jun Wang
Zi-Jun Wang
ZHZihua Hu
Zihua Hu
EMEmmanuel Matas
Emmanuel Matas
ZYZhen Yan
Zhen Yan

28 March 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
OHObelia Haida
Obelia Haida
TSTareq Al Sagheer
Tareq Al Sagheer
ABAnais Balbous
Anais Balbous
MFMaureen Francheteau
Maureen Francheteau
EMEmmanuel Matas
Emmanuel Matas
Mohamed JABERMohamed JABER
Mohamed JABER
Infections during gestation and the consequent maternal immune activation (MIA) increase the risk of developing neuropsychiatric disorders in infants and throughout life, including autism spectrum disorders (ASD). ASD is a neurodevelopmental disorder that affects three times more males than females and is mainly characterized by deficits in social communication and restricted interests. Consistent findings also indicate that ASD patients suffer from movement disorders, although these symptoms are not yet considered as diagnosis criteria. Here we used the double-stranded RNA analog polyinosinic:polycytidylic acid (poly I:C) MIA animal model of ASD in mice and explored its effects in males and females on social and motor behavior. We then investigated brain areas implicated in controlling and coordinating movements, namely the nigro-striatal pathway, motor cortex and cerebellum. We show that male mice are more affected by this treatment than females as they show reduced social interactions as well as motor development and coordination deficits. Reduced numbers of Purkinje cells in the cerebellum was found more widespread and within distinct lobules in males than in females. Moreover, a reduced number of neurons was found in the motor cortex of males only. These results suggest that females are better protected against developmental insults leading to ASD symptoms in mice. They also point to brain areas that may be targeted to better manage social and motor consequences of ASD.

18 January 2019 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
ZWZi-Jun Wang
Zi-Jun Wang
PZPing Zhong
Ping Zhong
KMKaijie Ma
Kaijie Ma
JSJi-Seon Seo
Ji-Seon Seo
FYFengwei Yang
Fengwei Yang
ZYZhen Yan
Zhen Yan

19 April 2018 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
KMKaijie Ma
Kaijie Ma
LQLuye Qin
Luye Qin
EMEmmanuel Matas
Emmanuel Matas
LDLara J. Duffney
Lara J. Duffney
ALAiyi Liu
Aiyi Liu
ZYZhen Yan
Zhen Yan
Autism is a neurodevelopmental disorder characterized by social deficits and repetitive behaviors. Genetic screening has identified synaptic, transcriptional, and chromatin genes disrupted in autistic patients. Haploinsufficiency of Shank3, which encodes a scaffold protein at glutamatergic synapses, is causally linked to autism. Using a Shank3-deficient mouse model that exhibits prominent autism-like phenotypes, we have found that histone acetylation in the prefrontal cortex (PFC) is abnormally low, which can be reversed by MS-275 (also known as Entinostat, SNDX-275), a class I histone deacetylase (HDAC) inhibitor that is selectively potent in PFC. A brief (3-day) treatment with MS-275 (i.p.) led to the sustained (11 days) rescue of autistic social preference deficits in Shank3-deficient mice, without altering locomotion, motor coordination, anxiety, or the increased grooming. MS-275 treatment also rescued the diminished NMDAR surface expression and NMDAR function induced by Shank3 deficiency. Moreover, F-actin at synapses was restored and the transcription of actin regulators was elevated by MS-275 treatment of Shank3-deficient mice, which may contribute to the recovery of actin-based NMDAR synaptic delivery. Taken together, these results suggest that MS-275 treatment could normalize the aberrant epigenetic regulation of genes, leading to the amelioration of synaptic and social deficits associated with autism.

12 May 2016 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
NGNicole Gröger
Nicole Gröger
EMEmmanuel Matas
Emmanuel Matas
TGTomasz Gos
Tomasz Gos
ALAlexandra Lesse
Alexandra Lesse
GPGerd Poeggel
Gerd Poeggel
JBJörg Bock
Jörg Bock